Skip to main content
Equibles
SRTS logo

SRTS · Sensus Healthcare, Inc.

Track SRTS — free

Use SRTS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.19 -0.07 (-2.15%) At close · Sep 4
Rebalance outlook locked
Market Cap
$52.51M
Shares
16.46M

SRTS metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.19
Market cap
$52.51M

Price action

19 metrics
Price change (1W)
-9.4%
Price change (30D)
+3.2%
Price change (3M)
+18.1%
Price change (6M)
-24.9%
Price change (YTD)
-19.8%
Price change (1Y)
+0.3%
Trailing year
Price change (5Y)
-12.8%
52-week high
$5.30
52-week low
$2.69
Change from 52-week high
-39.8%
Change from 52-week low
+18.6%
Annualized volatility
64.8%
Beta
0.9
RSI (14D)
49.5
Price vs SMA 50
+3.2%
Price vs SMA 200
-15.1%
Avg volume (3M)
34,761
Relative volume
0.5
Average dollar volume
$107,004

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
16.46M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.0×
reciprocal yield 33.3%
P / book
1.4
reciprocal yield 70.2%
FCF yield
-13.3%
TTM · current market cap
Buyback yield
0.6%
P / FCF
—
P / operating cash flow
—
Earnings yield
-29.5%

Historical valuation

8 metrics
P / E historical average (3Y)
24.3×
reciprocal yield 4.1%
P / E historical average (5Y)
24.3×
reciprocal yield 4.1%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
36.4%
Operating margin
-75.7%
Trailing 12 months
Net margin
-88.5%
Gross profit (TTM)
$6.37M
Operating profit (TTM)
−$13.26M
Net income (TTM)
−$15.48M
Trailing 12 months
Diluted EPS (TTM)
$-0.94
FCF margin
-39.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.57

Growth

11 metrics
Revenue growth YoY
-68.7%
Year over year
Net income growth YoY
-216.1%
Revenue (TTM)
$17.51M
Trailing 12 months
EPS growth YoY
-214.6%
Shares change YoY
+0.9%
Year over year · more shares
Revenue CAGR (3Y)
-14.9%
Revenue CAGR (5Y)
+23.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-42.0%
Return on assets
-37.5%
Debt / equity
—
Current ratio
8.7
EBITDA (TTM)
−$12.86M
Free cash flow (TTM)
−$6.97M
Quick ratio
4.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$15.19M
Latest balance sheet
Cash & equivalents
$15.19M
Total assets
$41.26M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.80M
Capital expenditures (TTM)
$173,000
R&D (TTM)
$6.40M
SG&A (TTM)
$7.51M
Stock compensation (TTM)
$289,000
R&D / revenue
36.6%
Stock compensation / revenue
1.7%

Ownership (13F)

3 metrics
13F filers
40
13F filer change QoQ
-4
Institutional ownership
22.7%

Short interest

3 metrics
Short interest
1.3%
Latest settlement · 8.8 days to cover
Days to cover
8.8d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
$563,538
Insider-sentiment score
92 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1494891 CUSIP 81728J109 13F (30d) 28 filings 28 filers Visit website